Oral administration of vanadate to diabetic rats restores liver 6-phosphofructo-2-kinase content and mRNA

This publication has 44 references indexed in Scilit:

• Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus.
  Journal of Clinical Investigation, 1991
• Effects of vanadate on 6-phosphofructo 2-kinase activity and fructose 2,6-bisphosphate levels in cultured rat hepatocytes
  Cell Biochemistry and Function, 1990
• Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.
  Journal of Clinical Investigation, 1989
• Vanadate counteracts glucagon effects in isolated rat hepatocytes
  Life Sciences, 1989
• Direct modulation of insulin receptor protein tyrosine kinase by vanadate and anti-insulin receptor monoclonal antibodies
  Biochemical and Biophysical Research Communications, 1988
• Starvation or diabetes decreases the content but not the mRNA of 6‐phosphofructo‐2‐kinase in rat liver
  FEBS Letters, 1988
• Effects of diabetes on fructose 2,6-P2, glucose 1,6-P2 and 6-phosphofructo 2-kinase in rat liver
  Biochemical and Biophysical Research Communications, 1986
• Regulation of Rat Liver L‐Type Pyruvate Kinase mRNA by Insulin and by Fructose
  European Journal of Biochemistry, 1982
• Effects of vanadium on glucose metabolism
  Life Sciences, 1979
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976